Contribution of visceral fat accumulation and adiponectin to the clustering of metabolic abnormalities in a Japanese population

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 6, 2014, Pages 543-553

  Takahara, Mitsuyoshi ^a   Katakami, Naoto ^a   Kaneto, Hideaki ^a   Noguchi, Midori ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Amagasaki City Office   (Japan)

Author keywords

Metabolic syndrome; Structural equation modeling analysis; Visceral fat

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; INTRAABDOMINAL FAT; JAPANESE (PEOPLE); LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; CLUSTER ANALYSIS; ETHNOLOGY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; JAPAN; METABOLISM; RISK FACTOR; SYSTOLE;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; CHOLESTEROL, HDL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; RISK FACTORS; SYSTOLE; TRIGLYCERIDES; URIC ACID;

EID: 84903204247     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.22343     Document Type: Article

References (28)

1. The Examination Committee of Criteria for the Metabolic Syndrome in Japan: Definition and diagnostic criteria of the metabolic syndrome. J Japan Soc Intern Med, 2005; 94: 794-809
2. Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639
3. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006; 23: 469-480
4. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I: Statistical reassessment of the association between waist circumference and clustering metabolic abnormalities in Japanese population. J Atheroscler Thromb, 2012; 19: 767-778
5. Takahara M, Kaneto H, Shimomura I: High prevalence of normal waist circumference in Japanese employees with a cluster of metabolic abnormalities. J Atheroscler Thromb, 2013; 20: 310-312
6. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004; 68: 975-981
7. Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, Yamaguchi T, Funahashi T, Matsuzawa Y, Nakamura T, Shimomura I: A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care, 2005; 28: 451-453
8. Nishimura A, Sawai T: Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clin Chim Acta, 2006; 371: 163-168
9. Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T: Relationship between hyperuricemia and body fat distribution. Intern Med, 2007; 46: 1353-1358
10. Tamba S, Nishizawa H, Funahashi T, Okauchi Y, Ogawa T, Noguchi M, Fujita K, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Matsuzawa Y: Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med, 2008; 47: 1175-1180
11. Lopez-Bermejo A, Botas P, Funahashi T, Delgado E, Kihara S, Ricart W, Fernandez-Real JM: Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf), 2004; 60: 256-263
12. Kamada Y, Nakamura T, Funahashi T, Ryo M, Nishizawa H, Okauchi Y, Fukushima J, Yoshida Y, Kiso S, Shimomura I, Hayashi N: Visceral obesity and hypoadiponectinemia are significant determinants of hepatic dysfunction: An epidemiologic study of 3827 Japanese subjects. J Clin Gastroenterol, 2009; 43: 995-1000
13. Hui E, Xu A, Yang HB, Lam KSL: Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. J Diabetes Invest, 2013; 4: 413-425
14. Lemieux S, Despres JP, Moorjani S, Nadeau A, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ: Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia, 1994; 37: 757-764
15. Zhang Q, Lou S, Meng Z, Ren X: Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese. Clin Rheumatol, 2011; 30: 777-787
16. Oda E, Kawai R: Age-and gender-related differences in correlations between abdominal obesity and obesityrelated metabolic risk factors in Japanese. Intern Med, 2009; 48: 497-502
17. Meshkani R, Taghikhani M, Larijani B, Khatami S, Khoshbin E, Adeli K: The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta, 2006; 371: 169-175
18. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV: Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res, 2000; 8: 411-421
19. Biino G, Parati G, Concas MP, Adamo M, Angius A, Vaccargiu S, Pirastu M: Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates. PLoS One, 2013; 8: e59612
20. Shiina Y, Homma Y: Relationships between the visceral fat area on CT and coronary risk factor markers. Intern Med, 2013; 52: 1775-1780
21. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
22. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K: Diagnostic criteria for dyslipidemia. J Atheroscler Thromb, 2013; 20: 655-660
23. Bhowmik B, Munir BS, Diep LM, Siddiquee T, Habib SH, Samad MA, Khan AKA, Hussain A: Anthropometric indicators of obesity for identifying cardiometabolic risk factors in a rural Bangladeshi population. J Diabetes Invest, 2013; 4: 361-368
24. Okauchi Y, Iwahashi H, Okita K, Funahashi T, Kishida K, Noguchi M, Ohira T, Nakamura T, Imagawa A, Shimomura I: Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6-6.4%, with visceral fat accumulation, but not without visceral fat accumulation. J Diabetes Invest, 2013; 4: 454-459
25. Mukai N, Doi Y, Ninomiya T, Hirakawa Y, Nagata M, Yoshida D, Hata J, Fukuhara M, Nakamura U, T. K, Kiyohara Y: Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study. J Diabetes Invest, 2013, doi: 10.1111/jdi.12136
26. Oka R, Yagi K, Sakurai M, Nakamura K, Nagasawa SY, Miyamoto S, Nohara A, Kawashiri MA, Hayashi K, Takeda Y, Yamagishi M: Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb, 2012; 19: 814-822
27. Takahara M, Kaneto H, Shimomura I: Insulin resistance can be easily estimated by body mass index and waist circumference in a general Japanese population. J Atheroscler Thromb, 2013; 20: 401-403
28. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I: Prediction of the Presence of Insulin Resistance using General Health Checkup Data in Japanese Employees with Metabolic Risk Factors. J Atheroscler Thromb, 2013, doi: 10.5551/jat.18622